Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Cendakimab is an investigational monoclonal antibody that has garnered attention in the field of immunology and therapeutics. This biologic agent is designed to target and neutralize interleukin-13 (IL-13), a cytokine known to play a significant role in various inflammatory processes and disorders, particularly allergic diseases.
Cendakimab works by binding to IL-13 with high affinity, preventing its interaction with receptors IL-13Rα1 and IL-13Rα2
Cendakimab is being studied for its effectiveness in treating [Atopic …